[1]
2024. TP53 Mutation Type and Platinum-Free Interval in Patients with High-Grade Serous Ovarian Cancer. Voprosy onkologii. 70, 3 (Jul. 2024), 550–556. DOI:https://doi.org/10.37469/0507-3758-2024-70-3-550-556.